In patients with T2D, a fixed dose (10 U/day) or a body weight-based dose (0.1–0.2 U/kg/day) is recommended for initiating basal insulin therapy, although BBT is not recommended as the first insulin therapy in the ADA Standards of Medical Care in Diabetes4. The gene discussed is INS; the disease is type 2 diabetes mellitus.